MedTrace Logo

The WISE Trial - Walking Improvement for SCI With Exoskeleton

NCT02943915 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-10-31

Study results available
· View outcomes & findings →

Summary

A randomized, controlled trial comparing exoskeleton gait training with standard gait training or no gait training in community-dwelling participants with chronic incomplete spinal cord injury

Conditions

  • Injuries, Spinal Cord

Interventions

DEVICE

Ekso GT Rehabilitation Therapy

Walking Improvement for Spinal Cord Injuries with Exoskeleton

DEVICE

Body Weight Supported (BWS) Treadmill Training

Standard gait training using BWS PT and overground training

Sponsors & Collaborators

  • Burke Medical Research Institute

    collaborator OTHER

  • Ekso Bionics

    lead INDUSTRY

Principal Investigators

  • Dylan Edwards, PhD · Burke Medical Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2019-09-10
Completion
2019-09-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02943915 on ClinicalTrials.gov